Cardiac Biomarkers in Cardiology

Поділитися
Вставка
  • Опубліковано 16 вер 2021
  • Did you know that cardiac biomarkers can provide a path to better, earlier decision making. After many years of continuing research and clinical evidence generation, cardiac biomarkers now play a key (and often defining) role in clinical decision making for Cardiology.
    At Roche our continuing investment in cardiac biomarker superior performance, evidence, and reliability, will lead to earlier & more confident clinical decision making, improved patient management, and increased efficiency & cost management - and better outcomes for everyone in Australia.
    Subscribe to our UA-cam channel now: ua-cam.com/users/roche?su...
    Get in touch with us:
    www.roche.com/
    / roche
    / roche
    / roche
    / roche
    Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
    Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
    For more information and insights visit: www.roche.com/
  • Наука та технологія

КОМЕНТАРІ •